Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2456916, 7 pages
https://doi.org/10.1155/2017/2456916
Research Article

Lack of Clinical Relevance of ANA and ASMA Positivity in Patients with Liver Transplantation without a History of Autoimmune Diseases

1AOU San Giovanni di Dio e Ruggi d’Aragona, Liver Following Transplantation Centre, Department of Medicine and Surgery, University of Salerno, Salerno, Italy
2AOU San Giovanni di Dio e Ruggi d’Aragona, UOC Clinical Pathology Department, Salerno, Italy

Correspondence should be addressed to Fabiana Zingone; moc.kooltuo@enogniz.anaibaf

Received 28 September 2016; Revised 30 January 2017; Accepted 8 February 2017; Published 27 February 2017

Academic Editor: Dimitrios P. Bogdanos

Copyright © 2017 Lucienne Pellegrini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Dubel, O. Farges, Y. Sato, and H. Bismuth, “Development of anti-tissue antibodies in the rat liver transplant model,” Transplantation, vol. 65, no. 8, pp. 1135–1137, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. C.-Y. Chen, M.-C. Ho, J.-F. Wu et al., “Development of autoantibodies after pediatric liver transplantation,” Pediatric Transplantation, vol. 17, no. 2, pp. 144–148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Richter, E. Grabhorn, K. Helmke, M. P. Manns, R. Ganschow, and M. Burdelski, “Clinical relevance of autoantibodies after pediatric liver transplantation,” Clinical Transplantation, vol. 21, no. 3, pp. 427–432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Vergani and G. Mieli-Vergani, “Autoimmunity after liver transplantation,” Hepatology, vol. 36, no. 2, pp. 271–276, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Avitzur, B. Y. Ngan, M. Lao, A. Fecteau, and V. L. Ng, “Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation,” Journal of Pediatric Gastroenterology and Nutrition, vol. 45, no. 2, pp. 222–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Czaja, “Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation,” Digestive Diseases and Sciences, vol. 57, no. 9, pp. 2248–2266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Guido and P. Burra, “De novo autoimmune hepatitis after liver transplantation,” Seminars in Liver Disease, vol. 31, no. 1, pp. 71–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Foschi, C. A. Zavaglia, D. Fanti et al., “Autoimmunity after liver transplantation: a frequent event but a rare clinical problem,” Clinical Transplantation, vol. 29, no. 2, pp. 161–166, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Dubel, O. Farges, C. Johanet, M. Sebagh, and H. Bismuth, “High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection,” Transplantation, vol. 65, no. 8, pp. 1072–1075, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Cinquanta, N. Bizzaro, D. Villalta et al., “Linee guida per l’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche. Revisione 2015,” La Rivista Italiana della Medicina di Laboratorio, vol. 11, no. 4, pp. 205–224, 2015. View at Publisher · View at Google Scholar
  11. D. Villalta, “Diagnostica di laboratorio delle epatiti autoimmuni,” RIMeL—IJLaM, vol. 6, no. 4, 2010. View at Google Scholar
  12. Q.-Z. Li, D. R. Karp, J. Quan et al., “Risk factors for ANA positivity in healthy persons,” Arthritis Research & Therapy, vol. 13, article R38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. E. Wandstrat, F. Carr-Johnson, V. Branch et al., “Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus,” Journal of Autoimmunity, vol. 27, no. 3, pp. 153–160, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Salcedo, J. Vaquero, R. Baares et al., “Response to steroids in de novo autoimmune hepatitis after liver transplantation,” Hepatology, vol. 35, no. 2, pp. 349–356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. D. S. Pisetsky, “Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg?” Arthritis Research and Therapy, vol. 13, no. 2, article 109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. J. T. Smeenk, “Antinuclear antibodies: cause of disease or caused by disease?” Rheumatology, vol. 39, no. 6, pp. 581–584, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. Majka, K. D. Deane, L. A. Parrish et al., “Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis,” Annals of the Rheumatic Diseases, vol. 67, no. 6, pp. 801–807, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Vadasz, T. Haj, A. Kessel, and E. Toubi, “Age-related autoimmunity,” BMC Medicine, vol. 11, no. 1, article 94, 2013. View at Publisher · View at Google Scholar · View at Scopus